nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylprednisolone—systemic lupus erythematosus—primary biliary cirrhosis	0.377	0.514	CtDrD
Methylprednisolone—rheumatoid arthritis—primary biliary cirrhosis	0.356	0.486	CtDrD
Methylprednisolone—CYP3A4—Chenodeoxycholic acid—primary biliary cirrhosis	0.0664	0.426	CbGbCtD
Methylprednisolone—ABCB1—Colchicine—primary biliary cirrhosis	0.056	0.359	CbGbCtD
Methylprednisolone—CYP3A4—Colchicine—primary biliary cirrhosis	0.0336	0.215	CbGbCtD
Methylprednisolone—Miliaria—Ursodeoxycholic acid—primary biliary cirrhosis	0.00317	0.0362	CcSEcCtD
Methylprednisolone—Miliaria—Chenodeoxycholic acid—primary biliary cirrhosis	0.00317	0.0362	CcSEcCtD
Methylprednisolone—Metabolic acidosis—Colchicine—primary biliary cirrhosis	0.00263	0.03	CcSEcCtD
Methylprednisolone—Cardiomegaly—Ursodeoxycholic acid—primary biliary cirrhosis	0.00256	0.0292	CcSEcCtD
Methylprednisolone—Cardiomegaly—Chenodeoxycholic acid—primary biliary cirrhosis	0.00256	0.0292	CcSEcCtD
Methylprednisolone—ABCB1—Drug Induction of Bile Acid Pathway—SLC51B—primary biliary cirrhosis	0.00242	0.11	CbGpPWpGaD
Methylprednisolone—ABCB1—Drug Induction of Bile Acid Pathway—SLC51A—primary biliary cirrhosis	0.00184	0.0833	CbGpPWpGaD
Methylprednisolone—CYP3A4—Drug Induction of Bile Acid Pathway—SLC51B—primary biliary cirrhosis	0.00149	0.0677	CbGpPWpGaD
Methylprednisolone—Myopathy—Colchicine—primary biliary cirrhosis	0.00148	0.0169	CcSEcCtD
Methylprednisolone—Peptic ulcer—Ursodeoxycholic acid—primary biliary cirrhosis	0.0014	0.0159	CcSEcCtD
Methylprednisolone—Peptic ulcer—Chenodeoxycholic acid—primary biliary cirrhosis	0.0014	0.0159	CcSEcCtD
Methylprednisolone—Neuritis—Colchicine—primary biliary cirrhosis	0.00139	0.0159	CcSEcCtD
Methylprednisolone—ABCB1—Abacavir transmembrane transport—ABCG2—primary biliary cirrhosis	0.00125	0.0569	CbGpPWpGaD
Methylprednisolone—CYP3A4—Drug Induction of Bile Acid Pathway—SLC51A—primary biliary cirrhosis	0.00113	0.0513	CbGpPWpGaD
Methylprednisolone—Acne—Ursodeoxycholic acid—primary biliary cirrhosis	0.00111	0.0127	CcSEcCtD
Methylprednisolone—Acne—Chenodeoxycholic acid—primary biliary cirrhosis	0.00111	0.0127	CcSEcCtD
Methylprednisolone—ABCB1—Codeine and Morphine Metabolism—ABCC2—primary biliary cirrhosis	0.00101	0.0459	CbGpPWpGaD
Methylprednisolone—Fluid retention—Ursodeoxycholic acid—primary biliary cirrhosis	0.000886	0.0101	CcSEcCtD
Methylprednisolone—Fluid retention—Chenodeoxycholic acid—primary biliary cirrhosis	0.000886	0.0101	CcSEcCtD
Methylprednisolone—Oesophagitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000853	0.00973	CcSEcCtD
Methylprednisolone—Oesophagitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000853	0.00973	CcSEcCtD
Methylprednisolone—Ecchymosis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000844	0.00963	CcSEcCtD
Methylprednisolone—Ecchymosis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000844	0.00963	CcSEcCtD
Methylprednisolone—Blood alkaline phosphatase increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.000779	0.00889	CcSEcCtD
Methylprednisolone—Blood alkaline phosphatase increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.000779	0.00889	CcSEcCtD
Methylprednisolone—Cardiac failure congestive—Chenodeoxycholic acid—primary biliary cirrhosis	0.000747	0.00852	CcSEcCtD
Methylprednisolone—Cardiac failure congestive—Ursodeoxycholic acid—primary biliary cirrhosis	0.000747	0.00852	CcSEcCtD
Methylprednisolone—Injury—Ursodeoxycholic acid—primary biliary cirrhosis	0.000737	0.00841	CcSEcCtD
Methylprednisolone—Injury—Chenodeoxycholic acid—primary biliary cirrhosis	0.000737	0.00841	CcSEcCtD
Methylprednisolone—Amnesia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000721	0.00823	CcSEcCtD
Methylprednisolone—Amnesia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000721	0.00823	CcSEcCtD
Methylprednisolone—ABCB1—Abacavir transport and metabolism—ABCG2—primary biliary cirrhosis	0.000721	0.0327	CbGpPWpGaD
Methylprednisolone—Cardiac failure—Ursodeoxycholic acid—primary biliary cirrhosis	0.000694	0.00792	CcSEcCtD
Methylprednisolone—Cardiac failure—Chenodeoxycholic acid—primary biliary cirrhosis	0.000694	0.00792	CcSEcCtD
Methylprednisolone—Muscular weakness—Colchicine—primary biliary cirrhosis	0.000665	0.00759	CcSEcCtD
Methylprednisolone—Alanine aminotransferase increased—Colchicine—primary biliary cirrhosis	0.000665	0.00759	CcSEcCtD
Methylprednisolone—CYP3A4—Codeine and Morphine Metabolism—ABCC2—primary biliary cirrhosis	0.000624	0.0283	CbGpPWpGaD
Methylprednisolone—Breast disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000612	0.00699	CcSEcCtD
Methylprednisolone—Breast disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000612	0.00699	CcSEcCtD
Methylprednisolone—Alanine aminotransferase increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.000597	0.00682	CcSEcCtD
Methylprednisolone—Alanine aminotransferase increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.000597	0.00682	CcSEcCtD
Methylprednisolone—Pancreatitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000574	0.00655	CcSEcCtD
Methylprednisolone—Pancreatitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000574	0.00655	CcSEcCtD
Methylprednisolone—Neuropathy peripheral—Colchicine—primary biliary cirrhosis	0.000569	0.0065	CcSEcCtD
Methylprednisolone—ABCB1—Drug Induction of Bile Acid Pathway—ABCC2—primary biliary cirrhosis	0.000554	0.0251	CbGpPWpGaD
Methylprednisolone—Weight increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.000533	0.00608	CcSEcCtD
Methylprednisolone—Weight increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.000533	0.00608	CcSEcCtD
Methylprednisolone—Infestation NOS—Chenodeoxycholic acid—primary biliary cirrhosis	0.000522	0.00596	CcSEcCtD
Methylprednisolone—Infestation NOS—Ursodeoxycholic acid—primary biliary cirrhosis	0.000522	0.00596	CcSEcCtD
Methylprednisolone—Infestation—Ursodeoxycholic acid—primary biliary cirrhosis	0.000522	0.00596	CcSEcCtD
Methylprednisolone—Infestation—Chenodeoxycholic acid—primary biliary cirrhosis	0.000522	0.00596	CcSEcCtD
Methylprednisolone—Acute coronary syndrome—Chenodeoxycholic acid—primary biliary cirrhosis	0.000515	0.00587	CcSEcCtD
Methylprednisolone—Acute coronary syndrome—Ursodeoxycholic acid—primary biliary cirrhosis	0.000515	0.00587	CcSEcCtD
Methylprednisolone—Myocardial infarction—Ursodeoxycholic acid—primary biliary cirrhosis	0.000512	0.00584	CcSEcCtD
Methylprednisolone—Myocardial infarction—Chenodeoxycholic acid—primary biliary cirrhosis	0.000512	0.00584	CcSEcCtD
Methylprednisolone—Sweating—Ursodeoxycholic acid—primary biliary cirrhosis	0.0005	0.00571	CcSEcCtD
Methylprednisolone—Sweating—Chenodeoxycholic acid—primary biliary cirrhosis	0.0005	0.00571	CcSEcCtD
Methylprednisolone—NR3C1—Signaling events mediated by HDAC Class II—NUP210—primary biliary cirrhosis	0.000496	0.0225	CbGpPWpGaD
Methylprednisolone—Eye disorder—Colchicine—primary biliary cirrhosis	0.000487	0.00556	CcSEcCtD
Methylprednisolone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—primary biliary cirrhosis	0.000485	0.022	CbGpPWpGaD
Methylprednisolone—CYP3A4—Farnesoid X Receptor  Pathway—ABCB4—primary biliary cirrhosis	0.000476	0.0216	CbGpPWpGaD
Methylprednisolone—Haemoglobin—Ursodeoxycholic acid—primary biliary cirrhosis	0.000471	0.00537	CcSEcCtD
Methylprednisolone—Haemoglobin—Chenodeoxycholic acid—primary biliary cirrhosis	0.000471	0.00537	CcSEcCtD
Methylprednisolone—Mediastinal disorder—Colchicine—primary biliary cirrhosis	0.00047	0.00536	CcSEcCtD
Methylprednisolone—Rhinitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00047	0.00536	CcSEcCtD
Methylprednisolone—Rhinitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00047	0.00536	CcSEcCtD
Methylprednisolone—Haemorrhage—Ursodeoxycholic acid—primary biliary cirrhosis	0.000469	0.00535	CcSEcCtD
Methylprednisolone—Haemorrhage—Chenodeoxycholic acid—primary biliary cirrhosis	0.000469	0.00535	CcSEcCtD
Methylprednisolone—NR3C1—Transcription factor regulation in adipogenesis—PPARGC1A—primary biliary cirrhosis	0.000466	0.0211	CbGpPWpGaD
Methylprednisolone—Connective tissue disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00046	0.00525	CcSEcCtD
Methylprednisolone—Connective tissue disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00046	0.00525	CcSEcCtD
Methylprednisolone—NR3C1—FOXA2 and FOXA3 transcription factor networks—IGFBP1—primary biliary cirrhosis	0.00046	0.0209	CbGpPWpGaD
Methylprednisolone—Malnutrition—Colchicine—primary biliary cirrhosis	0.000454	0.00518	CcSEcCtD
Methylprednisolone—Visual impairment—Ursodeoxycholic acid—primary biliary cirrhosis	0.000452	0.00515	CcSEcCtD
Methylprednisolone—Visual impairment—Chenodeoxycholic acid—primary biliary cirrhosis	0.000452	0.00515	CcSEcCtD
Methylprednisolone—Eye disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000438	0.005	CcSEcCtD
Methylprednisolone—Eye disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000438	0.005	CcSEcCtD
Methylprednisolone—Cardiac disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000435	0.00496	CcSEcCtD
Methylprednisolone—Cardiac disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000435	0.00496	CcSEcCtD
Methylprednisolone—Angiopathy—Ursodeoxycholic acid—primary biliary cirrhosis	0.000425	0.00485	CcSEcCtD
Methylprednisolone—Angiopathy—Chenodeoxycholic acid—primary biliary cirrhosis	0.000425	0.00485	CcSEcCtD
Methylprednisolone—Immune system disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000423	0.00483	CcSEcCtD
Methylprednisolone—Immune system disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000423	0.00483	CcSEcCtD
Methylprednisolone—Mediastinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000422	0.00482	CcSEcCtD
Methylprednisolone—Mediastinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000422	0.00482	CcSEcCtD
Methylprednisolone—Arrhythmia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000419	0.00478	CcSEcCtD
Methylprednisolone—Arrhythmia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000419	0.00478	CcSEcCtD
Methylprednisolone—Angioedema—Colchicine—primary biliary cirrhosis	0.000415	0.00473	CcSEcCtD
Methylprednisolone—Malnutrition—Chenodeoxycholic acid—primary biliary cirrhosis	0.000408	0.00466	CcSEcCtD
Methylprednisolone—Malnutrition—Ursodeoxycholic acid—primary biliary cirrhosis	0.000408	0.00466	CcSEcCtD
Methylprednisolone—CYP3A4—Irinotecan Pathway—ABCC2—primary biliary cirrhosis	0.000399	0.0181	CbGpPWpGaD
Methylprednisolone—Myalgia—Colchicine—primary biliary cirrhosis	0.000387	0.00441	CcSEcCtD
Methylprednisolone—Arthralgia—Colchicine—primary biliary cirrhosis	0.000387	0.00441	CcSEcCtD
Methylprednisolone—Ill-defined disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000378	0.00432	CcSEcCtD
Methylprednisolone—Ill-defined disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000378	0.00432	CcSEcCtD
Methylprednisolone—Angioedema—Ursodeoxycholic acid—primary biliary cirrhosis	0.000373	0.00425	CcSEcCtD
Methylprednisolone—Angioedema—Chenodeoxycholic acid—primary biliary cirrhosis	0.000373	0.00425	CcSEcCtD
Methylprednisolone—Malaise—Chenodeoxycholic acid—primary biliary cirrhosis	0.000368	0.0042	CcSEcCtD
Methylprednisolone—Malaise—Ursodeoxycholic acid—primary biliary cirrhosis	0.000368	0.0042	CcSEcCtD
Methylprednisolone—Vertigo—Chenodeoxycholic acid—primary biliary cirrhosis	0.000366	0.00418	CcSEcCtD
Methylprednisolone—Vertigo—Ursodeoxycholic acid—primary biliary cirrhosis	0.000366	0.00418	CcSEcCtD
Methylprednisolone—Syncope—Chenodeoxycholic acid—primary biliary cirrhosis	0.000366	0.00417	CcSEcCtD
Methylprednisolone—Syncope—Ursodeoxycholic acid—primary biliary cirrhosis	0.000366	0.00417	CcSEcCtD
Methylprednisolone—Shock—Colchicine—primary biliary cirrhosis	0.000365	0.00416	CcSEcCtD
Methylprednisolone—Nervous system disorder—Colchicine—primary biliary cirrhosis	0.000363	0.00415	CcSEcCtD
Methylprednisolone—Skin disorder—Colchicine—primary biliary cirrhosis	0.00036	0.00411	CcSEcCtD
Methylprednisolone—Loss of consciousness—Ursodeoxycholic acid—primary biliary cirrhosis	0.000359	0.00409	CcSEcCtD
Methylprednisolone—Loss of consciousness—Chenodeoxycholic acid—primary biliary cirrhosis	0.000359	0.00409	CcSEcCtD
Methylprednisolone—Convulsion—Ursodeoxycholic acid—primary biliary cirrhosis	0.000353	0.00403	CcSEcCtD
Methylprednisolone—Convulsion—Chenodeoxycholic acid—primary biliary cirrhosis	0.000353	0.00403	CcSEcCtD
Methylprednisolone—Hypertension—Chenodeoxycholic acid—primary biliary cirrhosis	0.000352	0.00402	CcSEcCtD
Methylprednisolone—Hypertension—Ursodeoxycholic acid—primary biliary cirrhosis	0.000352	0.00402	CcSEcCtD
Methylprednisolone—Arthralgia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000347	0.00396	CcSEcCtD
Methylprednisolone—Arthralgia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000347	0.00396	CcSEcCtD
Methylprednisolone—Myalgia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000347	0.00396	CcSEcCtD
Methylprednisolone—Myalgia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000347	0.00396	CcSEcCtD
Methylprednisolone—Hypotension—Colchicine—primary biliary cirrhosis	0.000346	0.00395	CcSEcCtD
Methylprednisolone—Unspecified disorder of skin and subcutaneous tissue—Ursodeoxycholic acid—primary biliary cirrhosis	0.000345	0.00394	CcSEcCtD
Methylprednisolone—Unspecified disorder of skin and subcutaneous tissue—Chenodeoxycholic acid—primary biliary cirrhosis	0.000345	0.00394	CcSEcCtD
Methylprednisolone—Discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.000343	0.00392	CcSEcCtD
Methylprednisolone—Discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.000343	0.00392	CcSEcCtD
Methylprednisolone—CYP3A4—Drug Induction of Bile Acid Pathway—ABCC2—primary biliary cirrhosis	0.000342	0.0155	CbGpPWpGaD
Methylprednisolone—CYP3A4—Irinotecan Pathway—ABCG2—primary biliary cirrhosis	0.000339	0.0154	CbGpPWpGaD
Methylprednisolone—Musculoskeletal discomfort—Colchicine—primary biliary cirrhosis	0.000338	0.00385	CcSEcCtD
Methylprednisolone—Confusional state—Ursodeoxycholic acid—primary biliary cirrhosis	0.000336	0.00383	CcSEcCtD
Methylprednisolone—Confusional state—Chenodeoxycholic acid—primary biliary cirrhosis	0.000336	0.00383	CcSEcCtD
Methylprednisolone—ABCB1—Constitutive Androstane Receptor Pathway—ABCC2—primary biliary cirrhosis	0.000334	0.0151	CbGpPWpGaD
Methylprednisolone—Infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.000331	0.00377	CcSEcCtD
Methylprednisolone—Infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.000331	0.00377	CcSEcCtD
Methylprednisolone—Shock—Chenodeoxycholic acid—primary biliary cirrhosis	0.000328	0.00374	CcSEcCtD
Methylprednisolone—Shock—Ursodeoxycholic acid—primary biliary cirrhosis	0.000328	0.00374	CcSEcCtD
Methylprednisolone—Nervous system disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000326	0.00373	CcSEcCtD
Methylprednisolone—Nervous system disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000326	0.00373	CcSEcCtD
Methylprednisolone—Tachycardia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000325	0.00371	CcSEcCtD
Methylprednisolone—Tachycardia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000325	0.00371	CcSEcCtD
Methylprednisolone—Skin disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000323	0.00369	CcSEcCtD
Methylprednisolone—Skin disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000323	0.00369	CcSEcCtD
Methylprednisolone—Hyperhidrosis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000322	0.00367	CcSEcCtD
Methylprednisolone—Hyperhidrosis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000322	0.00367	CcSEcCtD
Methylprednisolone—Fatigue—Colchicine—primary biliary cirrhosis	0.000319	0.00365	CcSEcCtD
Methylprednisolone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—primary biliary cirrhosis	0.000318	0.0144	CbGpPWpGaD
Methylprednisolone—Hypotension—Ursodeoxycholic acid—primary biliary cirrhosis	0.000311	0.00355	CcSEcCtD
Methylprednisolone—Hypotension—Chenodeoxycholic acid—primary biliary cirrhosis	0.000311	0.00355	CcSEcCtD
Methylprednisolone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PPARGC1A—primary biliary cirrhosis	0.000308	0.0139	CbGpPWpGaD
Methylprednisolone—ABCB1—ABC-family proteins mediated transport—ABCC2—primary biliary cirrhosis	0.000304	0.0138	CbGpPWpGaD
Methylprednisolone—Musculoskeletal discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.000303	0.00346	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.000303	0.00346	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Colchicine—primary biliary cirrhosis	0.000303	0.00346	CcSEcCtD
Methylprednisolone—Insomnia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000301	0.00344	CcSEcCtD
Methylprednisolone—Insomnia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000301	0.00344	CcSEcCtD
Methylprednisolone—Paraesthesia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000299	0.00341	CcSEcCtD
Methylprednisolone—Paraesthesia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000299	0.00341	CcSEcCtD
Methylprednisolone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—primary biliary cirrhosis	0.000299	0.0135	CbGpPWpGaD
Methylprednisolone—Urticaria—Colchicine—primary biliary cirrhosis	0.000294	0.00336	CcSEcCtD
Methylprednisolone—Dyspepsia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000293	0.00334	CcSEcCtD
Methylprednisolone—Dyspepsia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000293	0.00334	CcSEcCtD
Methylprednisolone—Abdominal pain—Colchicine—primary biliary cirrhosis	0.000293	0.00334	CcSEcCtD
Methylprednisolone—Fatigue—Ursodeoxycholic acid—primary biliary cirrhosis	0.000287	0.00328	CcSEcCtD
Methylprednisolone—Fatigue—Chenodeoxycholic acid—primary biliary cirrhosis	0.000287	0.00328	CcSEcCtD
Methylprednisolone—CYP3A4—Tryptophan metabolism—OGDH—primary biliary cirrhosis	0.00028	0.0127	CbGpPWpGaD
Methylprednisolone—Feeling abnormal—Chenodeoxycholic acid—primary biliary cirrhosis	0.000274	0.00313	CcSEcCtD
Methylprednisolone—Feeling abnormal—Ursodeoxycholic acid—primary biliary cirrhosis	0.000274	0.00313	CcSEcCtD
Methylprednisolone—Hypersensitivity—Colchicine—primary biliary cirrhosis	0.000273	0.00312	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000272	0.00311	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000272	0.00311	CcSEcCtD
Methylprednisolone—Asthenia—Colchicine—primary biliary cirrhosis	0.000266	0.00303	CcSEcCtD
Methylprednisolone—Urticaria—Chenodeoxycholic acid—primary biliary cirrhosis	0.000264	0.00302	CcSEcCtD
Methylprednisolone—Urticaria—Ursodeoxycholic acid—primary biliary cirrhosis	0.000264	0.00302	CcSEcCtD
Methylprednisolone—Abdominal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000263	0.003	CcSEcCtD
Methylprednisolone—Abdominal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000263	0.003	CcSEcCtD
Methylprednisolone—Diarrhoea—Colchicine—primary biliary cirrhosis	0.000254	0.00289	CcSEcCtD
Methylprednisolone—Hypersensitivity—Ursodeoxycholic acid—primary biliary cirrhosis	0.000245	0.0028	CcSEcCtD
Methylprednisolone—Hypersensitivity—Chenodeoxycholic acid—primary biliary cirrhosis	0.000245	0.0028	CcSEcCtD
Methylprednisolone—Asthenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000239	0.00273	CcSEcCtD
Methylprednisolone—Asthenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000239	0.00273	CcSEcCtD
Methylprednisolone—Vomiting—Colchicine—primary biliary cirrhosis	0.000236	0.00269	CcSEcCtD
Methylprednisolone—Pruritus—Ursodeoxycholic acid—primary biliary cirrhosis	0.000236	0.00269	CcSEcCtD
Methylprednisolone—Pruritus—Chenodeoxycholic acid—primary biliary cirrhosis	0.000236	0.00269	CcSEcCtD
Methylprednisolone—Rash—Colchicine—primary biliary cirrhosis	0.000234	0.00267	CcSEcCtD
Methylprednisolone—Dermatitis—Colchicine—primary biliary cirrhosis	0.000233	0.00266	CcSEcCtD
Methylprednisolone—Headache—Colchicine—primary biliary cirrhosis	0.000232	0.00265	CcSEcCtD
Methylprednisolone—Diarrhoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.000228	0.0026	CcSEcCtD
Methylprednisolone—Diarrhoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.000228	0.0026	CcSEcCtD
Methylprednisolone—NR3C1—Circadian Clock—PPARGC1A—primary biliary cirrhosis	0.000224	0.0102	CbGpPWpGaD
Methylprednisolone—Dizziness—Ursodeoxycholic acid—primary biliary cirrhosis	0.00022	0.00251	CcSEcCtD
Methylprednisolone—Dizziness—Chenodeoxycholic acid—primary biliary cirrhosis	0.00022	0.00251	CcSEcCtD
Methylprednisolone—Nausea—Colchicine—primary biliary cirrhosis	0.00022	0.00251	CcSEcCtD
Methylprednisolone—Vomiting—Ursodeoxycholic acid—primary biliary cirrhosis	0.000212	0.00242	CcSEcCtD
Methylprednisolone—Vomiting—Chenodeoxycholic acid—primary biliary cirrhosis	0.000212	0.00242	CcSEcCtD
Methylprednisolone—Rash—Ursodeoxycholic acid—primary biliary cirrhosis	0.00021	0.0024	CcSEcCtD
Methylprednisolone—Rash—Chenodeoxycholic acid—primary biliary cirrhosis	0.00021	0.0024	CcSEcCtD
Methylprednisolone—Dermatitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00021	0.00239	CcSEcCtD
Methylprednisolone—Dermatitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00021	0.00239	CcSEcCtD
Methylprednisolone—Headache—Ursodeoxycholic acid—primary biliary cirrhosis	0.000209	0.00238	CcSEcCtD
Methylprednisolone—Headache—Chenodeoxycholic acid—primary biliary cirrhosis	0.000209	0.00238	CcSEcCtD
Methylprednisolone—ABCB1—Allograft Rejection—CXCR5—primary biliary cirrhosis	0.000206	0.00934	CbGpPWpGaD
Methylprednisolone—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC2—primary biliary cirrhosis	0.000206	0.00933	CbGpPWpGaD
Methylprednisolone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—ABCG2—primary biliary cirrhosis	0.000202	0.00916	CbGpPWpGaD
Methylprednisolone—Nausea—Ursodeoxycholic acid—primary biliary cirrhosis	0.000198	0.00226	CcSEcCtD
Methylprednisolone—Nausea—Chenodeoxycholic acid—primary biliary cirrhosis	0.000198	0.00226	CcSEcCtD
Methylprednisolone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—primary biliary cirrhosis	0.000196	0.00889	CbGpPWpGaD
Methylprednisolone—CYP3A4—Aflatoxin activation and detoxification—GGT1—primary biliary cirrhosis	0.000195	0.00884	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—CXCL9—primary biliary cirrhosis	0.000187	0.00848	CbGpPWpGaD
Methylprednisolone—ABCB1—Constitutive Androstane Receptor Pathway—PPARGC1A—primary biliary cirrhosis	0.000186	0.00841	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—AQP4—primary biliary cirrhosis	0.000183	0.00828	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—IL12A—primary biliary cirrhosis	0.000182	0.00825	CbGpPWpGaD
Methylprednisolone—ABCB1—HIF-1-alpha transcription factor network—IGFBP1—primary biliary cirrhosis	0.000179	0.0081	CbGpPWpGaD
Methylprednisolone—NR3C1—Circadian Clock—HIF1A—primary biliary cirrhosis	0.000175	0.00794	CbGpPWpGaD
Methylprednisolone—CYP3A4—Farnesoid X Receptor  Pathway—PPARGC1A—primary biliary cirrhosis	0.000174	0.00787	CbGpPWpGaD
Methylprednisolone—NR3C1—AP-1 transcription factor network—IL4—primary biliary cirrhosis	0.000167	0.00756	CbGpPWpGaD
Methylprednisolone—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—primary biliary cirrhosis	0.00016	0.00726	CbGpPWpGaD
Methylprednisolone—ABCB1—HIF-1-alpha transcription factor network—ABCG2—primary biliary cirrhosis	0.000159	0.00722	CbGpPWpGaD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—IL4—primary biliary cirrhosis	0.000147	0.00666	CbGpPWpGaD
Methylprednisolone—NR3C1—AP-1 transcription factor network—HIF1A—primary biliary cirrhosis	0.000144	0.00655	CbGpPWpGaD
Methylprednisolone—NR3C1—AP-1 transcription factor network—AGT—primary biliary cirrhosis	0.000144	0.00652	CbGpPWpGaD
Methylprednisolone—Dexamethasone—NOS2—primary biliary cirrhosis	0.000138	0.284	CrCbGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—DAG1—primary biliary cirrhosis	0.000115	0.00523	CbGpPWpGaD
Methylprednisolone—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—primary biliary cirrhosis	0.000114	0.00518	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—IL12B—primary biliary cirrhosis	0.000114	0.00518	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—PPARGC1A—primary biliary cirrhosis	0.000113	0.0051	CbGpPWpGaD
Methylprednisolone—Hydrocortisone—ABCG2—primary biliary cirrhosis	0.000108	0.223	CrCbGaD
Methylprednisolone—ABCB1—Allograft Rejection—CTLA4—primary biliary cirrhosis	0.000107	0.00487	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—PPARGC1A—primary biliary cirrhosis	9.73e-05	0.00441	CbGpPWpGaD
Methylprednisolone—Dexamethasone—ABCC2—primary biliary cirrhosis	9.13e-05	0.188	CrCbGaD
Methylprednisolone—NR3C1—Adipogenesis—HIF1A—primary biliary cirrhosis	8.8e-05	0.00399	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—AGT—primary biliary cirrhosis	8.77e-05	0.00397	CbGpPWpGaD
Methylprednisolone—NR3C1—AP-1 transcription factor network—MMP9—primary biliary cirrhosis	8.47e-05	0.00384	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—CD40LG—primary biliary cirrhosis	8.36e-05	0.00379	CbGpPWpGaD
Methylprednisolone—ABCB1—HIF-1-alpha transcription factor network—HIF1A—primary biliary cirrhosis	8.13e-05	0.00369	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—IL4—primary biliary cirrhosis	8.13e-05	0.00368	CbGpPWpGaD
Methylprednisolone—Dexamethasone—ABCG2—primary biliary cirrhosis	8.07e-05	0.166	CrCbGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—SLC4A2—primary biliary cirrhosis	7.98e-05	0.00362	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—HIF1A—primary biliary cirrhosis	7.61e-05	0.00345	CbGpPWpGaD
Methylprednisolone—ABCB1—HIF-1-alpha transcription factor network—NOS2—primary biliary cirrhosis	7.4e-05	0.00335	CbGpPWpGaD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—NFKB1—primary biliary cirrhosis	7.39e-05	0.00335	CbGpPWpGaD
Methylprednisolone—Prednisone—ALB—primary biliary cirrhosis	6.7e-05	0.138	CrCbGaD
Methylprednisolone—ABCB1—Allograft Rejection—CD80—primary biliary cirrhosis	6.22e-05	0.00282	CbGpPWpGaD
Methylprednisolone—NR3C1—Generic Transcription Pathway—CTGF—primary biliary cirrhosis	5.4e-05	0.00245	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—primary biliary cirrhosis	5.38e-05	0.00244	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—NFKB1—primary biliary cirrhosis	4.42e-05	0.002	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—LBR—primary biliary cirrhosis	3.74e-05	0.00169	CbGpPWpGaD
Methylprednisolone—CYP3A4—Biological oxidations—GGT1—primary biliary cirrhosis	3.35e-05	0.00152	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—AQP4—primary biliary cirrhosis	3.31e-05	0.0015	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—NUP210—primary biliary cirrhosis	3.26e-05	0.00148	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—ABCC2—primary biliary cirrhosis	3.18e-05	0.00144	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—NUP210—primary biliary cirrhosis	2.91e-05	0.00132	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—OGDH—primary biliary cirrhosis	2.7e-05	0.00123	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—ABCG2—primary biliary cirrhosis	2.7e-05	0.00122	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—CTGF—primary biliary cirrhosis	2.6e-05	0.00118	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PDHX—primary biliary cirrhosis	2.41e-05	0.00109	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—LBR—primary biliary cirrhosis	2.3e-05	0.00104	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ABCB4—primary biliary cirrhosis	2.27e-05	0.00103	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—DLAT—primary biliary cirrhosis	2.27e-05	0.00103	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—primary biliary cirrhosis	2.02e-05	0.000915	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—OGDH—primary biliary cirrhosis	1.67e-05	0.000755	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PDHX—primary biliary cirrhosis	1.48e-05	0.000673	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—DLAT—primary biliary cirrhosis	1.4e-05	0.000633	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ABCB4—primary biliary cirrhosis	1.4e-05	0.000633	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—NUP210—primary biliary cirrhosis	1.36e-05	0.000617	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ABCG2—primary biliary cirrhosis	1.27e-05	0.000574	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CTGF—primary biliary cirrhosis	1.09e-05	0.000492	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GOT2—primary biliary cirrhosis	1.08e-05	0.000488	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	1.06e-05	0.000478	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GOT1—primary biliary cirrhosis	9.29e-06	0.000421	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GGT1—primary biliary cirrhosis	9.29e-06	0.000421	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—NUP210—primary biliary cirrhosis	8.39e-06	0.00038	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PPARGC1A—primary biliary cirrhosis	8.27e-06	0.000375	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ABCG2—primary biliary cirrhosis	7.8e-06	0.000353	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CTGF—primary biliary cirrhosis	6.69e-06	0.000303	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GOT2—primary biliary cirrhosis	6.63e-06	0.000301	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—AGT—primary biliary cirrhosis	6.44e-06	0.000292	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GOT1—primary biliary cirrhosis	5.72e-06	0.000259	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GGT1—primary biliary cirrhosis	5.72e-06	0.000259	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PPARGC1A—primary biliary cirrhosis	5.09e-06	0.000231	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ALB—primary biliary cirrhosis	4.94e-06	0.000224	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—AGT—primary biliary cirrhosis	3.97e-06	0.00018	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ALB—primary biliary cirrhosis	3.04e-06	0.000138	CbGpPWpGaD
